Format

Send to

Choose Destination
See comment in PubMed Commons below
Postgrad Med J. 2010 Mar;86(1013):136-42. doi: 10.1136/pgmj.2008.072058.

Understanding the risk of hyperkalaemia in heart failure: role of aldosterone antagonism.

Author information

1
Heart Failure and Heart Transplant Program, Department of Cardiology, FLENI, Buenos Aires, Argentina.

Abstract

The risk of hyperkalaemia in patients with heart failure has increased in the past few years together with the evolution of pharmacological treatment for these patients. This significant change has been associated with the introduction of angiotensin converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), and aldosterone antagonists. High potassium concentrations in heart failure could lead to life threatening events, and therefore should be taken seriously. In this review we summarise the information about potassium homeostasis in heart failure and the current risk of developing potentially serious hyperkalaemia, particularly in association with the use of aldosterone antagonists.

PMID:
20237007
DOI:
10.1136/pgmj.2008.072058
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center